Protective effect of ginsenoside re on acute gastric mucosal lesion induced by compound 48/80

Journal of Ginseng Research

Volumn 38, Issue 2, 2014, Pages 89-96

  Lee, Sena ^a   Kim, Myung Gyou ^a   Ko, Sung Kwon ^a   Kim, Hye Kyung ^b   Leem, Kang Hyun ^a   Kim, Youn Jung ^c  

^a Semyung University   (South Korea)

^b Hanseo University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Gastritis; Ginsenoside re; Mucosa; Panax ginseng

Indexed keywords

COMPOUND 48-80; GINSENOSIDE RE; HEXOSAMINE; MYELOPEROXIDASE; PROTEIN BAX; PROTEIN BCL 2; THIOBARBITURIC ACID REACTIVE SUBSTANCE; XANTHINE OXIDASE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BERRY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG ISOLATION; ENZYME ACTIVITY; GINSENG; LIPID PEROXIDATION; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH MUCOSA LESION; STOMACH MUCUS;

EID: 84937514535     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgr.2013.10.001     Document Type: Article

References (37)

1. Shibata S, Tanaka O, Ando T, Sado M, Tsushima S, Ohsawa T. Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuine sapogenin of ginseng saponins. Chem Pharm Bull (Tokyo) 1966;14:595-600.
2. Kim YK, Yoo DS, Xu H, Park NI, Kim HH, Choi JE, Park SU. Ginsenoside content of berries and roots of three typical Korean ginseng (Panax ginseng) cultivars. Nat Prod Commun 2009;4:903-6.
3. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-8.
4. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, Rue PA, Bell GI, et al. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005;1740:319-25.
5. Yang CY, Wang J, Zhao Y, Shen L, Jiang X, Xie ZG, Liang N, Zhang L, Chen ZH. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components. J Ethnopharmacol 2010;130:231-6.
6. Lee OH, Lee HH, Kim JH, Lee BY. Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes. Phytother Res 2011;25:768-73.
7. Bae HM, Cho OS, Kim SJ, Im BO, Cho SH, Lee S, Kim MG, Kim KT, Leem KH, Ko SK. Inhibitory effects of ginsenoside re isolated from ginseng berry on histamine and cytokine release in human mast cells and human alveolar epithelial cells. J Ginseng Res 2012;36:369-74.
8. Liu YW, Zhu X, Li W, Lu Q, Wang JY, Wei YQ, Yin XX. Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats. Pharmacol Biochem Behav 2012;101:93-8.
9. Lee JS, Kwon KA, Jung HS, Kim JH, Hahm KB. Korea red ginseng on Helicobacter pylori-induced halitosis: newer therapeutic strategy and a plausible mechanism. Digestion 2009;80:192-9.
10. Zajac P, Holbrook A, Super ME, Vogt M. An overview: current clinical guidelines for the evaluation, diagnosis, treatment, and management of dyspepsia. Osteopathic Family Physician 2013;5:79-85.
11. Berardi RR, Tankanow RM, Nostrant TT. Comparison of famotidine with cimetidine and ranitidine. Clin Pharm 1988;7:271-84.
12. Takeuchi K, Ohtsuki H, Okabe S. Pathogenesis of compound 48/80-induced gastric lesions in rats. Dig Dis Sci 1986;31:392-400.
13. Takeuchi K, Ohtsuki H, Nobuhara Y, Okabe S. Mechanisms of irritative activity of compound 48/80 on rat gastric mucosa. Digestion 1986;33:34-44.
14. Ohta Y, Kobayashi T, Hayashi T, Inui K, Yoshino J, Nakazawa S. Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Phytother Res 2006;20: 256-62.
15. Chen LM, Zhou XM, Cao YL, Hu WX. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Prod Res 2008;10: 439-45.
16. Vacca LL. Laboratory manual of histochemistry. New York: Raven Press; 1985.
17. Kitagawa H, Takeda F, Kohei H. A simple method for estimation of gastric mucus and effects of antiulcerogenic agents on the decrease in mucus during water-immersion stress in rats. Arzneimittelforschung 1986;36:1240-4.
18. Neuhaus OW, Letzring M. Determination of hexosamines in conjunction with electrophoresis on starch. Anal Chem 1957;29:1230-3.
19. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345-52.
20. Hashimoto S. A new spectrophotometric assay method of xanthine oxidase in crude tissue homogenate. Anal Biochem 1974;62:426-35.
21. Shi SR, Liu C, Balgley BM, Lee C, Taylor CR. Protein extraction from formalinfixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem 2006;54:739-43.
22. Yamabe N, Kim YJ, Lee S, Cho EJ, Park SH, Ham J, Kim HY, Kang KS. Increase in antioxidant and anticancer effects of ginsenoside Re-lysine mixture by Maillard reaction. Food Chem 2013;138:876-83.
23. Shi J, Xue W, Zhao WJ, Li KX. Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats. Acta Pharmacol Sin 2013;34:214-20.
24. Lee KW, Jung SY, Choi SM, Yang EJ. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Complement Altern Med 2012;12:196.
25. Marieb EN. Human anatomy and physiology. 5th ed. San Francisco: Benjamin Cummings; 2001.
26. Rothschild AM. Mechanisms of histamine release by compound 48-80. Br J Pharmacol 1970;38:253-62.
27. Ohta Y, Kobayashi T, Nishida K, Ishiguro I. Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions is gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci 1997;42:1221-32.
28. Younan F, Pearson J, Allen A, Venables C. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease. Gastroenterology 1982;82:827-31.
29. Tarnawski A, Szabo IL, Husain SS, Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physiol Paris 2001;95:337-44.
30. Sanyal AK, Mitra PK, Goel RK. A modified method to estimate dissolved mucosubstances in gastric juice. Indian J Exp Biol 1983;21:78-80.
31. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
32. Follin P, Dahlgren C. Altered O2-/H2O2 production ratio by in vitro and in vivo primed human neutrophils. Biochem Biophys Res Commun 1990;167:970-6.
33. Ohta Y, Kobayashi T, Ishiguro I. Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci 1999;44:1865-74.
34. Qiao WL, Wang GM, Shi Y, Wu JX, Qi YJ, Zhang JF, Sun H, Yan CD. Differential expression of Bcl-2 and Bax during gastric ischemia-reperfusion of rats. World J Gastroenterol 2011;17:1718-24.
35. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-9.
36. Northington FJ, Ferriero DM, Flock DL, Martin LJ. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci 2001;21:1931-8.
37. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994;145:1323-36.